Cargando…

B Cells and Antibodies as Targets of Therapeutic Intervention in Neuromyelitis Optica Spectrum Disorders

The first description of neuromyelitis optica by Eugène Devic and Fernand Gault dates back to the 19th century, but only the discovery of aquaporin-4 autoantibodies in a major subset of affected patients in 2004 led to a fundamentally revised disease concept: Neuromyelits optica spectrum disorders (...

Descripción completa

Detalles Bibliográficos
Autores principales: Traub, Jan, Husseini, Leila, Weber, Martin S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825598/
https://www.ncbi.nlm.nih.gov/pubmed/33419217
http://dx.doi.org/10.3390/ph14010037